세계 반려동물용 백신 시장 : 제품 유형별, 종별, 유통 채널별, 지역별

The global companion animal vaccine market is estimated to be valued at US$ 3.35 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Companion animal vaccinations are those administered to pets (such as dogs and cats) to stimulate their immune responses. Companion animal vaccines, in other words, are used to improve the functioning of the immune system in pets and other animals. Moreover, vaccination can protect companion animals or pets from a variety of diseases, including parvovirus, distemper, leptospirosis, lastomycosis, psittacosis, cat scratch disease, kennel cough, and others. Routine vaccination is a vital part of animal healthcare that ensures companion animals health and well-being. Key players operating in the market are focusing on research and development activities, clinical trials, approval, and the launch of novel vaccines for the treatment of companion animals, which is expected to drive market growth globally.

Market Dynamics

The key players in the vaccine industry are focusing on the development of novel vaccines for prevention against new diseases such as rift valley fever, Bluetongue Virus (BTV), etc. Moreover, major players in the market are focusing on inorganic stratergies such as mergers, acquisitions, and collaboration for vaccine developments for veterinary applications. Increasing investments by governments to support manufacturing and distribution of vaccines is expected to propel market growth for companion animal vaccine. For instane, In June 2022, ARTES Biotechnology, a globally active Research and development company specializing in developing biopharmaceutical production processes, Q-Biologicals NV, a Belgium-based biotechnology company, and instrAction GmbH, a Germany-based multimodal chromatography technology company, partnered to collaborate on the development of a virus-like particle (VLP)-based vaccine platform and stable formulation especially suited for veterinary applications. The intent of "Plurivax" is to develop a stable production platform and an adapted, high-quality process to have an effective and usable integrated best practice suitable for several veterinary vaccines. Thus, the availability of the product in the market, which includes virus-like particles (VLP), is expected to offer opportunities for vaccine manufacturers to develop novel vaccines for veterinary use.

Key features of the study:

• This report provides an in-depth analysis of the global companion animal vaccine market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global companion animal vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva Ltd., Merck & Co. Inc., Virbac, Zoetis Inc., HIPRA, Biogenesis Bago, Ourofino Animal Health, Croda International Plc, KM Biologics, Indian Immunologicals Ltd., Sinovac, Kyoto Biken Laboratories, Inc., HESTER BIOSCIENCES LIMITED, Calier, Bioveta, a.s
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global companion animal vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal vaccine market

Detailed Segmentation:

• Global Companion Animal Vaccine Market , By Product Type:
  • Attenuated Live Vaccine
  • Conjugate Vaccine
  • Inactivated Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • DNA Vaccine
  • Recombinant Vaccine
• Global Companion Animal Vaccine Market , By Species Type:
  • Canine
  • Feline
  • Equine
  • Avians
  • Others
• Global Companion Animal Vaccine Market , By Distribution channel:
  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Others
• Global Companion Animal Vaccine Market , By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim Gmb
  • Ceva Ltd.
  • Merck & Co Inc.
  • Virbac, Inc.
  • Zoetis Inc.
  • HIPRA
  • Biogenesis Bago
  • Ourofino Animal Health.
  • Croda International Plc
  • KM Biologics
  • Indian Immunologicals Ltd.
  • Sinovac
  • Kyoto Biken Laboratories, Inc.
  • HESTER BIOSCIENCES LIMITED
  • Calier
  • Bioveta, a.s

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Species Type
  • Market Snippet, By Distribution Channel
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Product Launches/Approvals
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Companion Animal Vaccine Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Companion Animal Vaccine Market, By Product Type, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Attenuated Live Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Conjugate Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Inactivated Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Subunit Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Toxoid Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• DNA Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trend
• Recombinant Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trend

6. Global Companion Animal Vaccine Market, By Species Type, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Canine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Feline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Equine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Avians
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

7. Global Companion Animal Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• Veterinary Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Veterinary Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Veterinary Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Companion Animal Vaccine Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • Elanco Animal Health Incorporated
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Boehringer Ingelheim GmbH
  • Ceva Ltd.
  • Merck & Co. Inc.
  • Virbac
  • Zoetis Inc.
  • HIPRA
  • Biogenesis Bago
  • Ourofino Animal Health.
  • Croda International Plc
  • KM Biologics
  • Indian Immunologicals Ltd.
  • Sinovac
  • Kyoto Biken Laboratories, Inc.
  • HESTER BIOSCIENCES LIMITED
  • Calier
  • Bioveta, a.s

10. Section

• References
• Research Methodology
• About us and Sales Contact